Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AccuStem Sciences Inc - SIC # 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ACUT
Over the counter
2835
https://accustem.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AccuStem Sciences Inc
AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic Partnership
- Jul 17th, 2023 11:00 am
AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to Address Unanswered Clinical Questions in Early Stage Breast Cancer
- Jul 11th, 2023 11:00 am
Goldman Small Cap Research Publishes New Research Report on AccuStem Sciences, Inc.
- Jun 20th, 2023 12:09 pm
AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals
- Jun 6th, 2023 5:00 am
AccuStem Announce Strategic Clinical and Operational Partnership
- May 31st, 2023 11:00 am
Scroll